State Street’s Ambrx Biopharma Inc AMAM Stock Holding History

State Street’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,015	Closed	-$712K	–	4440
2023 Q4	$712K	Sell	50,015 -385	-0.8%	-$4.38K	﹤0.01%	3556
2023 Q3	$580K	Buy	+50,400	New	+$686K	﹤0.01%	3634

State Street's AMAM Position: Q1 2024 in Review

State Street sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 50,015 shares — an estimated $712K sold.

State Street first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $712K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

State Street reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
State Street sold 50,015 Ambrx Biopharma Inc shares in Q1 2024, an estimated $712K.
State Street first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
State Street's Ambrx Biopharma Inc position peaked at $712K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.